Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000935836-24-000779
Filing Date
2024-12-23
Accepted
2024-12-23 20:08:57
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 12936
2 ino13g.htm EX-99.1 AGREEMENT 4888
  Complete submission text file 0000935836-24-000779.txt   19847
Mailing Address 660 W. GERMANTOWN PIKE SUITE 110 PLYMOUTH MEETING PA 19462
Business Address 660 W. GERMANTOWN PIKE SUITE 110 PLYMOUTH MEETING PA 19462 8584103134
INOVIO PHARMACEUTICALS, INC. (Subject) CIK: 0001055726 (see all company filings)

EIN.: 330969592 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-60487 | Film No.: 241575376
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 919 NW BOND STREET SUITE 204 BEND OR 97703
Business Address 919 NW BOND STREET SUITE 204 BEND OR 97703 541-647-5673
Stonepine Capital Management, LLC (Filed by) CIK: 0001440771 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G